Galmed Pharmaceuticals Ltd (GLMD)
0.385
-0.01
(-1.91%)
USD |
NASDAQ |
Apr 26, 16:00
0.385
0.00 (0.00%)
After-Hours: 16:41
Galmed Pharmaceuticals Cash and Short Term Investments (Quarterly): 12.64M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.64M |
| September 30, 2023 | 13.31M |
| June 30, 2023 | 9.33M |
| March 31, 2023 | 12.15M |
| December 31, 2022 | 13.78M |
| September 30, 2022 | 19.21M |
| June 30, 2022 | 22.40M |
| March 31, 2022 | 28.74M |
| December 31, 2021 | 34.82M |
| September 30, 2021 | 41.90M |
| June 30, 2021 | 51.06M |
| March 31, 2021 | 58.80M |
| December 31, 2020 | 50.89M |
| September 30, 2020 | 58.58M |
| June 30, 2020 | 63.43M |
| March 31, 2020 | 68.89M |
| December 31, 2019 | 75.49M |
| September 30, 2019 | 79.73M |
| June 30, 2019 | 83.62M |
| March 31, 2019 | 86.56M |
| December 31, 2018 | 90.19M |
| Date | Value |
|---|---|
| September 30, 2018 | 92.32M |
| June 30, 2018 | 94.10M |
| March 31, 2018 | 15.50M |
| December 31, 2017 | 19.00M |
| September 30, 2017 | 8.958M |
| June 30, 2017 | 9.155M |
| March 31, 2017 | 11.65M |
| December 31, 2016 | 15.45M |
| September 30, 2016 | 18.31M |
| June 30, 2016 | 16.68M |
| March 31, 2016 | 19.97M |
| December 31, 2015 | 23.00M |
| September 30, 2015 | 25.32M |
| June 30, 2015 | 27.81M |
| March 31, 2015 | 29.89M |
| December 31, 2014 | 31.99M |
| September 30, 2014 | 35.34M |
| June 30, 2014 | 37.40M |
| March 31, 2014 | 39.77M |
| December 31, 2013 | 0.137M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
9.33M
Minimum
Jun 2023
83.62M
Maximum
Jun 2019
42.04M
Average
41.90M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Compugen Ltd | 50.68M |
| Pluri Inc | 30.62M |
| BioLine Rx Ltd | 42.99M |
| Can Fite Biofarma Ltd | 8.922M |
| BiomX Inc | 14.91M |